Companies: 10,795·Total market cap: $144.5T
BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.

BVXVNASDAQHealthcare
$1.36
+$0.01(+0.74%)
Market Cap$4966625
P/E Ratio—
52W High$11.49
52W Low$0.63
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

BiondVax Pharmaceuticals Ltd. (BVXV) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BVXV · as of Jun 9, 2026

Key Statistics

EPS (TTM)$1.18bvxv eps ttm · bvxv earnings per shareEarnings history
PE Ratio (TTM)1.2×bvxv pe ratio ttm · bvxv price to earningsPE Ratio deep dive
Revenue (TTM)0.00bvxv revenue ttm · bvxv annual revenueFull revenue history
Dividend YieldNo Dividenddoes bvxv pay dividends · bvxv dividend yieldDividend history
Shares Outstanding2.6Mbvxv shares outstanding · bvxv floatShares outstanding history
Next EarningsTBAbvxv earnings date · bvxv next earningsEarnings history

Explore BiondVax Pharmaceuticals Ltd. Data

bvxv stock data · financials
Market Cap$5.0Mbvxv market cap · bvxv valuation
Analyst Forecast—
DividendsNo Dividenddoes biondvax pharmaceuticals ltd. pay dividends · bvxv dividend yield
Revenue—biondvax pharmaceuticals ltd. annual revenue · bvxv revenue
EarningsEPS $-0.20+99.44%bvxv earnings · bvxv eps
PE Ratio1.2×bvxv pe ratio · bvxv price to earnings

Financial Snapshot

Full Financials
FY 2022Revenue$0.00
202020212022
biondvax pharmaceuticals ltd. revenue · bvxv revenue 2022
FY 2022Net Income-$531000.00▲ +98.95% YoY
202020212022
biondvax pharmaceuticals ltd. net income · bvxv profit 2022
FY 2022EPS$-0.20▲ +99.44% YoY
202020212022
bvxv eps · biondvax pharmaceuticals ltd. earnings per share 2022
TTM:Revenue: $0.00Net Income: $7.8MEPS: $1.18View income statement →

Stock Performance

Full History
1D+0.00%
1W+56.32%
1M+0.00%
3M-2.16%
YTD-54.82%
1Y-80.43%
5Y-97.57%

About BiondVax Pharmaceuticals Ltd.

CEOAmir Reichman
IPO DateMay 12, 2015
Employees33
CountryIL
Websitebiondvax.com

BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company currently in its development stage. Its core mission involves the research, production, and market introduction of therapeut…

BiotechnologyHealthcareNASDAQADRIL

what is biondvax pharmaceuticals ltd. · bvxv stock overview · biondvax pharmaceuticals ltd. company profile · who is biondvax pharmaceuticals ltd. ceo · bvxv NASDAQ · biondvax pharmaceuticals ltd. headquarters · biondvax pharmaceuticals ltd. business segments

About Stock Overview & Key Data

BiondVax Pharmaceuticals Ltd. (BVXV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 12, 2015. As of the latest trading session, BVXV stock price is $1.36, with a market capitalization of $5.0M. The stock has returned -80.43% over the past 12 months and -54.82% year-to-date.

In fiscal year 2022, BiondVax Pharmaceuticals Ltd. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, BiondVax Pharmaceuticals Ltd. (BVXV) stock price is $1.36. The stock is traded on NASDAQ under the ticker symbol BVXV. The 52-week range is $0.63 – $11.49.

BVXV stock priceBVXV quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice